The invention relates to the use of a composition from a plant extract of Withania somnifera, to prevent, treat of delay the progression of .alpha.-synucleinopathies, including Parkinson disease.
The term .alpha.-synucleinopathies is usually employed to define a group of neurodegenerative disorders